HLOSF Dividend: Healios KK Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

HLOSF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	112	560	121	90	41	27
Revenue Growth (YoY)	-79%	363%	34%	120%	52%	-70%
Cost of Revenue	157	128	13	--	--	--
Gross Profit	-45	432	108	--	--	--
Selling, General & Admin	1,210	1,365	1,116	1,378	1,649	1,155
Research & Development	1,907	1,960	2,304	3,808	3,700	2,986
Operating Expenses	3,040	3,281	3,488	5,247	5,420	4,223
Other Non Operating Income (Expenses)	-2	95	33	133	100	-3
Pretax Income	-5,797	-4,061	-3,626	-5,330	-4,462	-5,378
Income Tax Expense	188	166	187	-160	450	135
Net Income	-5,987	-4,235	-3,823	-5,169	-4,910	-5,512
Net Income Growth	11%	11%	-26%	5%	-11%	15%
Shares Outstanding (Diluted)	104.4	88.47	68	57.01	52.59	51.42
Shares Change (YoY)	16%	30%	19%	8%	2%	3%
EPS (Diluted)	-57.34	-47.86	-56.21	-90.66	-93.36	-107.19
EPS Growth	-4%	-15%	-38%	-3%	-13%	12%
Free Cash Flow	-2,611	-2,124	-2,850	-4,863	-5,390	-4,259
Free Cash Flow Per Share	-25	-24	-41.9	-85.3	-102.48	-82.82
Gross Margin	-40.17%	77.14%	89.25%	--	--	--
Operating Margin	-2,754.46%	-508.75%	-2,793.38%	-5,730%	-13,119.51%	-15,540.74%
Profit Margin	-5,345.53%	-756.25%	-3,159.5%	-5,743.33%	-11,975.6%	-20,414.81%
Free Cash Flow Margin	-2,331.25%	-379.28%	-2,355.37%	-5,403.33%	-13,146.34%	-15,774.07%
EBITDA	-2,798	-2,840	-3,312	-5,086	-5,306	-4,112
EBITDA Margin	-2,498.21%	-507.14%	-2,737.19%	-5,651.11%	-12,941.46%	-15,229.62%
D&A For EBITDA	287	9	68	71	73	84
EBIT	-3,085	-2,849	-3,380	-5,157	-5,379	-4,196
EBIT Margin	-2,754.46%	-508.75%	-2,793.38%	-5,730%	-13,119.51%	-15,540.74%
Effective Tax Rate	-3.24%	-4.08%	-5.15%	3%	-10.08%	-2.51%